Header Logo

JEFFREY SHERER

Concepts (76)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Bipolar Disorder
4
2019
346
0.410
 Why?
Antipsychotic Agents
4
2017
375
0.340
 Why?
Antidepressive Agents
3
2017
288
0.310
 Why?
Psychotropic Drugs
2
2019
124
0.280
 Why?
Diphosphonates
1
2007
37
0.280
 Why?
Refuse Disposal
1
2006
5
0.260
 Why?
Imidazoles
1
2007
199
0.250
 Why?
Dementia
3
2021
448
0.250
 Why?
Environmental Pollutants
1
2006
68
0.250
 Why?
Drug Prescriptions
2
2017
217
0.230
 Why?
Environmental Exposure
1
2006
217
0.220
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2006
255
0.210
 Why?
Bone Neoplasms
1
2007
429
0.200
 Why?
Urinary Bladder, Overactive
1
2021
28
0.190
 Why?
Medication Adherence
2
2015
387
0.170
 Why?
Weight Gain
2
2019
401
0.160
 Why?
Nursing Homes
2
2010
95
0.160
 Why?
Prostatic Neoplasms
1
2007
1512
0.150
 Why?
Atomoxetine Hydrochloride
1
2017
15
0.140
 Why?
Child Psychiatry
1
2017
17
0.140
 Why?
Adrenergic Uptake Inhibitors
1
2017
27
0.140
 Why?
Central Nervous System Stimulants
1
2017
125
0.130
 Why?
Physicians, Primary Care
1
2017
94
0.130
 Why?
Nebulizers and Vaporizers
1
2015
57
0.120
 Why?
Body Mass Index
2
2019
1541
0.120
 Why?
Attention Deficit Disorder with Hyperactivity
1
2017
216
0.110
 Why?
Patient Readmission
1
2015
366
0.100
 Why?
Patient Discharge
1
2015
485
0.090
 Why?
Practice Patterns, Physicians'
1
2017
713
0.090
 Why?
Homes for the Aged
1
2010
24
0.090
 Why?
Cholinergic Antagonists
1
2010
51
0.090
 Why?
United States
7
2021
10637
0.090
 Why?
Computers, Handheld
1
2009
33
0.080
 Why?
Pharmacists
1
2009
83
0.080
 Why?
Drug Utilization Review
1
2009
33
0.080
 Why?
Pulmonary Disease, Chronic Obstructive
1
2015
596
0.080
 Why?
Health Care Surveys
1
2009
284
0.070
 Why?
United States Environmental Protection Agency
1
2006
7
0.070
 Why?
Retrospective Studies
5
2021
16033
0.060
 Why?
Male
11
2021
60117
0.060
 Why?
United States Food and Drug Administration
1
2006
148
0.060
 Why?
Aged
6
2021
19098
0.060
 Why?
Pharmaceutical Preparations
1
2006
80
0.060
 Why?
Aged, 80 and over
3
2010
6372
0.050
 Why?
Cohort Studies
2
2014
4710
0.050
 Why?
Galantamine
1
2021
10
0.050
 Why?
Rivastigmine
1
2021
17
0.050
 Why?
Female
10
2021
65549
0.050
 Why?
Humans
12
2021
123223
0.050
 Why?
Muscarinic Antagonists
1
2021
38
0.050
 Why?
Adolescent
5
2019
19110
0.050
 Why?
Medicaid
2
2014
245
0.050
 Why?
Cholinesterase Inhibitors
1
2021
90
0.050
 Why?
Child
5
2019
24240
0.040
 Why?
Withholding Treatment
1
2019
67
0.040
 Why?
Medicare
1
2021
424
0.040
 Why?
Antineoplastic Agents
1
2007
1661
0.040
 Why?
Middle Aged
3
2015
26016
0.030
 Why?
Body Weight
1
2019
1001
0.030
 Why?
Bronchodilator Agents
1
2015
153
0.030
 Why?
Risk
1
2014
747
0.030
 Why?
Cross-Sectional Studies
2
2010
3378
0.020
 Why?
Treatment Outcome
1
2007
12141
0.020
 Why?
Proportional Hazards Models
1
2014
1306
0.020
 Why?
Prescriptions
1
2009
39
0.020
 Why?
Regression Analysis
1
2009
771
0.020
 Why?
Psychotic Disorders
1
2009
140
0.020
 Why?
Time Factors
1
2017
6221
0.020
 Why?
Activities of Daily Living
1
2009
405
0.020
 Why?
Follow-Up Studies
1
2014
5049
0.020
 Why?
Predictive Value of Tests
1
2010
2112
0.020
 Why?
Sex Factors
1
2009
1260
0.020
 Why?
Prevalence
1
2010
2406
0.010
 Why?
Anxiety
1
2009
957
0.010
 Why?
Prospective Studies
1
2009
6040
0.010
 Why?
Adult
1
2009
29072
0.010
 Why?
SHERER's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (76)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_